|
NZ707571A
|
|
Compositions and methods for nanopolymer-based nucleic acid delivery
|
|
EP2563371A1
|
|
Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
|
|
WO2011130479A2
|
|
Application of polymeric materials to screens to facilitate hemostasis and wound healing
|
|
NZ599338A
|
|
Complexes of il-15 and il-15ralpha and uses thereof
|
|
NZ616957A
|
|
Hemostatic compositions and therapeutic regimens
|
|
EP1601757A2
|
|
Cell-polymer fiber compositions and use thereof
|
|
NZ541489A
|
|
Topically applied vasoconstrictor for treatment in cardic catheterization complications
|
|
US6743783B1
|
|
Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
|
|
US2002106792A1
|
|
Methods and compositions for poly-β-1-4-N-acetylglucosamine cell therapy system
|
|
US2002019367A1
|
|
Compositions and methods for modulation of vascular structure and/or function
|
|
US6063911A
|
|
Methods and compositions for treatment of cell proliferative disorders
|
|
WO9639122A1
|
|
POLY-β-1→4-N-ACETYLGLUCOSAMINE
|
|
US5635493A
|
|
Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics
|
|
US5846952A
|
|
Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery
|
|
US5624679A
|
|
Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers
|
|
US5686115A
|
|
Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
|
|
CA2372026A1
|
|
Poly-beta-1->4-n-acetylglucosamine
|
|
CA2604073A1
|
|
Poly-.beta.-1.fwdarw.4-n-acetylglucosamine
|
|
US5622834A
|
|
Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
|
